ProfileGDS5822 / ILMN_1256824
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 67% 80% 71% 70% 81% 51% 78% 76% 77% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 139.167
GSM1276600PDAC Late Ablation Control 2152.980
GSM1276601PDAC Late Ablation Control 381.971
GSM1276602PDAC Late Ablation 149.570
GSM1276603PDAC Late Ablation 2164.281
GSM1276604PDAC Late Ablation 324.851
GSM1303940PDAC Late Ablation_anti-CTLA4 1106.678
GSM1303941PDAC Late Ablation_anti-CTLA4 2122.476
GSM1303942PDAC Late Ablation_anti-CTLA4 3135.877